Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04067895
Other study ID # EP1
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 6, 2019
Est. completion date September 2024

Study information

Verified date August 2022
Source Medical University of Vienna
Contact Catharina Chiari, Dr.
Phone +43 1 40400
Email catharina.chiari@meduniwien.ac.at
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This observational study is to document the application of human bone graft in the surgical treatment (epiphysiodesis) of leg length discrepancy or primordial gigantism and its subsequent healing process.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date September 2024
Est. primary completion date September 2023
Accepts healthy volunteers No
Gender All
Age group 10 Years to 18 Years
Eligibility Inclusion Criteria: - Planned epiphysiodesis to stop the growing of a bone indicated by leg length discrepancies or primordial gigantism - Age 10-18 years - Written consent to participate in the study after previous written and oral education (additional consent for the participation of minors in the study after prior written and oral education by at least one parent) Exclusion Criteria: - Insufficient knowledge of the german language - Foreseeable compliance issues - Neoplastic diseases, malignant bone tumors, rheumatoid arthritis - Patients with non-treated pre-existing conditions, which could be the cause of leg length differences - Active osteomyelitis - Ulcerations in the area of the skin of the surgical area - Immunosuppressive drugs that can not be discontinued

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
epiphysiodesis
All patients undergo surgical treatment of leg lengths discrepancies or primordial gigantism. Human bone graft screws will be used to stop the distraction of the growth plate.

Locations

Country Name City State
Austria General Hospital Vienna Vienna

Sponsors (2)

Lead Sponsor Collaborator
Medical University of Vienna Surgebright Gmbh

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary formation of a bone bridge based on x-rays or MRI: Is as formation of a bone bridge visible? YES/NO How many millimeters? mm 1 year
Primary incidence of surgical revisions Was a surgical revision done postoperatively? YES/NO 1 year
Primary incidence of additional surgery Was an additional surgery necessary to stop growth? YES/NO; Which one? 1 year
Primary incidence of cracking of the screw based on x-rays or MRI: Is a crack of the screw visible? YES/NO 1 year
Primary incidence of a dislocation of the screw based on x-rays or MRI: Is the screw dislocated? YES/NO 1 year
Primary incidence of postoperative inflammatory complications Is a postoperative inflammatory complication recognizable? YES/NO 1 year
Primary cystic brightening around the screw based on x-rays or MRI: Is a cystic brightening around the screw visible? YES/NO 1 year
Primary sclerosing around the screw based on x-rays or MRI: Is a sclerosis around the screw visible? YES/NO 1 year
Primary evaluation of postoperative pain (VAS) The visual analogue scale (VAS) is a vertical line, 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extremes (0mm = no pain - 100mm = worst imaginable pain). A higher score indicates more pain. 1 year
Secondary evaluation of swelling Is a swelling in the surgery area visible? NO/MILD/MODERATE/SEVERE 1 year
Secondary evaluation of wound healing disorder Is a disorder of the wound healing recognizable? NO/MILD/MODERATE/SEVERE 1 year
Secondary evaluation of hematoma Is a hematoma in the surgery area visible? NO/MILD/MODERATE/SEVERE 1 year
Secondary patient satisfaction (VAS) The visual analogue scale (VAS) is a vertical line, 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extremes (0mm = very satisfied - 100mm = not satisfied at all). A higher score indicates less satisfaction. 1 year
Secondary Knee Outcome Survey - Activities of Daily Living Scale (KOS-ADL) The KOS ADL score includes 14 questions and is divided in 2 subscales, symptoms (6 items, max. score 30) and functional restrictions (8 items, max. score 40). The scores of the answers range from 0 to 5 points. 0 points mean no impairment of everyday activities, while 5 points represent the greatest possible impairment. All points are summed up.
From this, the KOS-ADL score is calculated as the proportion of the total response points from the possible maximum score (70) in percent. KOS ADL Score [%] = ( symptoms pts. + functional restrictions pts.)*100/70. The percentage ranges from 0-100%. 0% means no impairment, while 100% represents the greatest possible impairment.
1 year
Secondary International Knee Documentation Committee Subjective Knee Form (IKDC Score) The IKDC Score contains 19 questions (7 questions for symptomatology, 10 concerning function, 2 about sport activity). The lowest function level or the highest symptom level receives the score value 1. The highest function level or the lowest symptom level is given the number n according to the number n of possible answers. With the exception of question 10 "Functioning before knee injury", the remaining 18 response points are summed up. This gives the "raw sum". The lowest possible score is 18 and the maximum possible score is 87. The raw sum is converted into a scale of 0 to 100 using the following formula: ((raw score - lowest possible score)/score range)*100. 0 points mean the greatest possible impairment, while 100 points mean complete freedom from symptoms and functioning. The IKDC score can only be calculated if at least 16 of the 18 questions have been answered. 1 year
Secondary Revised questionnaire to assess Health-Related Quality of Life in children and adolescents (KINDL) The KINDL is a generic instrument for assessing Health-Related Quality of Life in children and adolescents aged 3 years and older. There are 3 versions available for different age groups: Kiddy-KINDL 4-6 years, Kid-KINDL 7-13 years, Kiddo-KINDL 14-17 years. The questionnaires used in this study (Kid-KINDL and Kiddo-KINDL) provide 24 Likert-scaled items associated with 6 dimensions: physical well-being ,emotional well-being, self-esteem, family, friends, and school. All versions also contain an additional section 'disease' with 6 items. They can be completed in case of illness or hospitalization. The items and sub-scales are calculated according to the KINDL manual and a higher score corresponds to a higher health-related quality of life. 1 year